Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Tecfidera
Tecfidera
After Alzheimer’s collapse, Biogen must win Tecfidera patent challenge
EP Vantage
Mon, 03/25/19 - 11:57 am
Biogen
Alzheimer's disease
Tecfidera
generics
Mylan
14 Drugs Earn Billions for These Massachusetts Biotechs
BioSpace
Wed, 03/6/19 - 09:59 am
Massachusetts
Boston
Biogen
Tecfidera
Benepali
Shire
Takeda
Vyvanse
Vertex Pharmaceuticals
Orkambi
Kalydeco
Alexion
Soliris
Strensiq
Sanofi Genzyme
Lantus
Ironwood Pharmaceuticals
Linzess
New insight into how Biogen's Tecfidera works may lead to better MS therapies
Fierce Biotech
Sat, 03/2/19 - 12:49 pm
Biogen
Tecfidera
MS
multiple sclerois
R&D
Mylan takes step toward knocking down key patent for Biogen's top-seller
Biopharma Dive
Thu, 02/7/19 - 03:26 pm
Mylan
Biogen
Tecfidera
patents
inter partes review
Forward Pharma loses appeal in Tecfidera patent dispute with Biogen
Reuters
Wed, 10/24/18 - 11:46 pm
Biogen
Tecfidera
MS
Forward Pharma
What's beyond hepatitis C in the drug launch hit parade? Ibrance and Tecfidera, for two
Fierce Pharma
Mon, 02/26/18 - 11:30 am
drug launches
hepatitis C
Ibrance
Tecfidera
Biogen
Pfizer
Gilead Sciences
How Biogen Inc. Makes Most of Its Money
Motley Fool
Thu, 07/13/17 - 05:43 pm
Biogen
Tecfidera
Tysabri
MS
multiple sclerosis
Biogen aims to block Tecfidera generics with flurry of lawsuits
Bizjournals.com
Tue, 07/4/17 - 11:22 pm
Biogen
Tecfidera
generics
MS
multiple sclerosis
Novartis
Sandoz
Mylan Labs
Why Roche's New Drug Is Bad News For Biogen
Barron's
Sun, 04/9/17 - 12:20 pm
Roche
Biogen
Ocrevus
multiple sclerosis
MS
Tysabri
Tecfidera
Forward Pharma Intends to Appeal Decision in Patent Interference Proceeding with Biogen Inc.
Yahoo
Sat, 04/1/17 - 08:07 am
Biogen
Tecfidera
patents
Forward Pharma
MS
multiple sclerosis
Biogen Wins Tecfidera Patent Case
Investopedia
Wed, 03/22/17 - 10:02 am
Biogen
Tecfidera
patents
Kyle Bass
MS
multiple sclerosis
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat
Fierce Pharma
Wed, 02/15/17 - 09:41 am
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
generics
Tecfidera
Biogen
Gilenya
Novartis
Aubagio
Sanofi
Biogen profit drops 22 pct due to Tecfidera-related costs
Yahoo/Reuters
Thu, 01/26/17 - 10:26 am
Biogen
earnings
Tecfidera
Biogen to pay $1.25B settlement in multiple sclerosis drug case
Bizjournals.com
Tue, 01/17/17 - 11:09 am
Biogen
Tecfidera
Forward Pharma
MS
multiple sclerosis
patents
Biogen recruits Jamie-Lynn Sigler for Tecfidera campaign
Medical Marketing and Media
Wed, 12/14/16 - 09:14 am
Biogen
celebrity endorsements
Tecfidera
MS
multiple sclerosis
Biogen may have edge in high-stakes Tecfidera patent battle, analyst says
Bizjournals.com
Sat, 12/3/16 - 09:24 am
Biogen
Tecfidera
MS
multiple sclerosis
patents
Forward Pharma
Biogen's Tecfidera faces outside pressure
BioPharma Dive
Thu, 12/1/16 - 04:29 pm
Biogen
Tecfidera
multiple sclerosis
MS
patents
Forward Pharma
What puts a new drug launch in line for victory? Ask Gilead, Biogen and J&J
Fierce Pharma
Thu, 11/17/16 - 10:01 am
Gilead Sciences
Biogen
JNJ
drug launches
AbbVie
Sovaldi
Imbruvica
Tecfidera
Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness
Fierce Pharma
Mon, 10/31/16 - 09:40 am
Biogen
Tecfidera
Amgen
Enbrel
drug pricing
Novartis' Is Challenging Biogen on Biogen's Own Turf
Motley Fool
Wed, 10/26/16 - 09:19 pm
Novartis
Biogen
Gilenya
Tecfidera
MS
multiple sclerosis
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »